# L-arginine in Severe Asthma Patients Grouped by Exhaled Nitric Oxide Levels

> **NCT01841281** · PHASE2 · COMPLETED · sponsor: **Nicholas Kenyon** · enrollment: 54 (actual)

## Conditions studied

- Asthma
- Inflammation

## Interventions

- **DRUG:** L-Arginine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01841281
- **Lead sponsor:** Nicholas Kenyon
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2018-08
- **Final completion:** 2019-12
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2020-04-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01841281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01841281, "L-arginine in Severe Asthma Patients Grouped by Exhaled Nitric Oxide Levels". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT01841281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*